Growth Metrics

Incyte (INCY) Non-Current Assets (2010 - 2026)

Incyte posted quarterly Non-Current Assets of $1.9 billion for Q1 2026, down 17.27% year-on-year from $2.2 billion in Q1 2025, and down 4.1% on a QoQ basis from $1.9 billion in Q4 2025.

Incyte (INCY) has 17 years of Non-Current Assets data on file, last reported at $1.9 billion in Q1 2026.

  • For the quarter ending Q1 2026, Non-Current Assets fell 17.27% year-over-year to $1.9 billion; the trailing twelve-month figure through Mar 2026 stood at $8.0 billion (down 8.31% YoY), and the FY2025 full-year result was $1.9 billion, down 12.3% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $1.9 billion, down from $1.9 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $2.3 billion in Q1 2024 and bottomed at $1.7 billion in Q3 2022.
  • The 5-year median for Non-Current Assets is $2.0 billion (2023), against an average of $2.0 billion.
  • The widest annual swing landed in 2022, when Non-Current Assets jumped 45.78%; it then declined 17.27% in 2026.
  • A 5-year view of Non-Current Assets shows it stood at $1.7 billion in 2022, then increased by 22.23% to $2.1 billion in 2023, then gained by 3.21% to $2.2 billion in 2024, then fell by 12.3% to $1.9 billion in 2025, then fell by 4.1% to $1.9 billion in 2026.
  • The last three Non-Current Assets figures came in at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $2.1 billion (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn - 4.56 Mn
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn - 62,953.78
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn 486.60 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn - 5.83 Mn
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn - 30.30 Mn
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn 14.75 Bn
7 Evaxion A 64.16 Bn 64.14 Bn - -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn 22.66 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn 910.24 Mn
10 Incyte 19.28 Bn 15.27 Bn 1.17 Bn 1.85 Bn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 1.85 Bn
Dec 31, 2025 1.93 Bn
Sep 30, 2025 2.05 Bn
Jun 30, 2025 2.18 Bn
Mar 31, 2025 2.24 Bn
Dec 31, 2024 2.21 Bn
Sep 30, 2024 2.20 Bn
Jun 30, 2024 2.09 Bn
Mar 31, 2024 2.29 Bn
Dec 31, 2023 2.14 Bn
Sep 30, 2023 1.99 Bn
Jun 30, 2023 1.94 Bn
Mar 31, 2023 1.83 Bn
Dec 31, 2022 1.75 Bn
Sep 30, 2022 1.69 Bn
Jun 30, 2022 1.69 Bn
Mar 31, 2022 1.77 Bn
Dec 31, 2021 1.81 Bn
Sep 30, 2021 1.28 Bn
Jun 30, 2021 1.28 Bn
Mar 31, 2021 1.21 Bn
Dec 31, 2020 1.20 Bn
Sep 30, 2020 1.15 Bn
Jun 30, 2020 1.13 Bn
Mar 31, 2020 1.04 Bn
Dec 31, 2019 945.26 Mn
Sep 30, 2019 67.60 Mn
Jun 30, 2019 889.01 Mn
Mar 31, 2019 849.66 Mn
Dec 31, 2018 61.60 Mn
Sep 30, 2018 62.80 Mn
Jun 30, 2018 799.07 Mn
Mar 31, 2018 836.46 Mn
Dec 31, 2017 64.80 Mn
Sep 30, 2017 832.98 Mn
Jun 30, 2017 794.64 Mn
Mar 31, 2017 788.17 Mn
Dec 31, 2016 644.42 Mn
Sep 30, 2016 65.30 Mn
Jun 30, 2016 625.85 Mn
Mar 31, 2016 168.36 Mn
Dec 31, 2015 165.07 Mn
Sep 30, 2015 33.70 Mn
Jun 30, 2015 197.35 Mn
Mar 31, 2015 170.48 Mn
Dec 31, 2014 116.90 Mn
Sep 30, 2014 122.65 Mn
Jun 30, 2014 101.96 Mn
Mar 31, 2014 85.66 Mn
Dec 31, 2013 73.77 Mn
Sep 30, 2013 23.66 Mn
Jun 30, 2013 20.85 Mn
Mar 31, 2013 21.17 Mn
Dec 31, 2012 20.91 Mn
Sep 30, 2012 17.81 Mn
Jun 30, 2012 17.81 Mn
Mar 31, 2012 17.43 Mn
Dec 31, 2011 18.18 Mn
Sep 30, 2011 24.81 Mn
Jun 30, 2011 24.74 Mn
Mar 31, 2011 33.64 Mn
Dec 31, 2010 34.13 Mn